Partner with NuPotential

NuPotential has several corporate alliances pending in which major cell therapy and other firms engaged in technologies relying on nuclear reprogramming will take advantage of NuPotential’s proprietary cell reprogramming technology to improve their own internal development programs for therapeutics and/or improvement of nuclear transfer technologies.  Areas of interest include:

Provision of autologous progenitor cells for cell therapy development.
Co-development of NuPotential’s proprietary cell reprogramming technology for specific
therapeutic applications.
Co-development of commercial applications reliant upon somatic cell nuclear transfer.
Joint SBIR/STTR grants with academic researchers engaged in regenerative
medicine research applications.
Other activities related to the field of cell therapy on a case-by-case basis.